StonvexLoading…
StonvexStonvexStonvexCore line items from MDLZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $38.54B | $36.44B | $36.02B | $31.50B |
Operating Income | $3.55B | $6.34B | $5.50B | $3.53B |
Net Income | $2.45B | $4.61B | $4.96B | $2.72B |
EPS (Diluted) | $1.89 | $3.42 | $3.62 | $1.96 |
Total Assets | $71.49B | $68.50B | $71.39B | $71.16B |
Total Liabilities | $45.60B | $41.54B | $43.02B | $44.24B |
Cash & Equivalents | $2.19B | $1.40B | $1.88B | $1.95B |
Free Cash Flow OCF − CapEx | $3.23B | $3.52B | $3.60B | $3.00B |
Shares Outstanding | 1.30B | 1.35B | 1.37B | 1.39B |